Stock Earnings

Question 1

What are Edwards Lifesciences Corp's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Edwards Lifesciences Corp has a total asset of $13,055, Net profit of $4,174

Question 2

What are the key financial ratios for EW?

Accepted Answer

Edwards Lifesciences Corp's Current ratio is 4.27, has a Net margin is 76.74, sales per share of $9.07.

Question 3

How is Edwards Lifesciences Corp's revenue broken down by segment or geography?

Accepted Answer

Edwards Lifesciences Corp largest revenue segment is Transcatheter Aortic Valve Replacement, at a revenue of 4,106,100,000 in the most earnings release.For geography, United States is the primary market for Edwards Lifesciences Corp, at a revenue of 3,206,000,000.

Question 4

Is Edwards Lifesciences Corp profitable?

Accepted Answer

yes, according to the latest financial statements, Edwards Lifesciences Corp has a net profit of $4,174

Question 5

Does Edwards Lifesciences Corp have any liabilities?

Accepted Answer

yes, Edwards Lifesciences Corp has liability of 3,056

Question 6

How many outstanding shares for Edwards Lifesciences Corp?

Accepted Answer

Edwards Lifesciences Corp has a total outstanding shares of 588.6

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	5,883	5,439	5,010	4,464	5,232	4,386
Revenue Growth (YoY)	5%	9%	12%	-15%	19%	1%
Cost of Revenue	1,283	1,117	978	723	1,248	1,080
Gross Profit	4,600	4,322	4,031	3,740	3,983	3,305
Selling, General & Admin	1,974	1,789	1,582	1,357	1,493	1,228
Research & Development	1,082	1,053	962	843	903	760
Operating Expenses	2,968	2,841	2,519	2,165	2,272	2,002
Other Non Operating Income (Expenses)	30	7	4	1	1	-1
Pretax Income	1,572	1,548	1,372	1,519	1,702	916
Income Tax Expense	235	152	152	195	198	93
Net Income	1,367	4,174	1,402	1,521	1,503	823
Net Income Growth	-67%	198%	-8%	1%	83%	-21%
Shares Outstanding (Diluted)	585.7	599.3	609.4	624.2	631.2	631.9
Shares Change (YoY)	-2%	-2%	-2%	-1%	0%	-1%
EPS (Diluted)	2.33	6.96	2.3	2.43	2.38	1.3
EPS Growth	-66%	202.99%	-5%	2%	83%	-21%
Free Cash Flow	799	259	629	953	1,402	647
Free Cash Flow Per Share	1.36	0.43	1.03	1.52	2.22	1.02
Gross Margin	78.19%	79.46%	80.45%	83.78%	76.12%	75.35%
Operating Margin	27.72%	27.21%	30.17%	35.25%	32.68%	29.7%
Profit Margin	23.23%	76.74%	27.98%	34.07%	28.72%	18.76%
Free Cash Flow Margin	13.58%	4.76%	12.55%	21.34%	26.79%	14.75%
EBITDA	1,787	1,635	1,656	1,713	1,844	1,410
EBITDA Margin	30.37%	30.06%	33.05%	38.37%	35.24%	32.14%
D&A For EBITDA	156	155	144	139	134	107
EBIT	1,631	1,480	1,512	1,574	1,710	1,303
EBIT Margin	27.72%	27.21%	30.17%	35.25%	32.68%	29.7%
Effective Tax Rate	14.94%	9.81%	11.07%	12.83%	11.63%	10.15%

Edwards Lifesciences Corp (EW) Price

EW Stock Price Chart

EW Income

Follow-Up Questions